# APP‐mediated intracellular signaling rescues sleep impairment and blood–brain barrier leakage in Alzheimer's disease mouse model

**Authors:** Clémentine Puech, Anjana Sadanand, Neil Coleman, Marilyn Ikhane, Mohammad Badran, Rong Wang, David Gozal, Angèle T. Parent

PMC · DOI: 10.1002/alz.71134 · Alzheimer's & Dementia · 2026-02-03

## TL;DR

A protein fragment called mAICD improves sleep, brain barrier function, and memory in a mouse model of Alzheimer's disease.

## Contribution

APP-mediated signaling, specifically mAICD and its interaction with GαS, is shown to rescue sleep and BBB integrity in AD mice.

## Key findings

- mAICD expression rescues sleep and cognitive impairments in AD mice.
- mAICD prevents blood–brain barrier leakage and promotes astrocyte redistribution.
- GαS interaction with mAICD is critical for preserving BBB, sleep, and cognition.

## Abstract

Amyloid beta peptide (Aβ) accumulation in the brain is an Alzheimer´s disease (AD) hallmark. Sleep disturbances hamper Aβ production and clearance, thereby exacerbating the Aβ burden. The mechanisms involved remain unclear. We reported that amyloid precursor protein (APP), the Aβ source, possesses intracellular signaling that attenuates Aβ production and prevents cognitive decline in AD mice. Our follow‐up study assessed whether enhancing APP‐mediated signaling affected sleep.

We expressed a membrane‐tethered APP intracellular domain (mAICD) and a variant lacking the GαS‐interacting site in AD mouse brains. Sleep patterns, cognitive behaviors, blood–brain barrier (BBB) integrity, and gliosis were examined.

Sleep, BBB integrity, and memory were strongly correlated. mAICD expression rescued sleep and cognitive function impairments, prevented BBB leakage, and promoted astrocyte redistribution surrounding the neurovascular units in AD mice. GαS interaction with mAICD was critical.

APP‐mediated signaling plays a key role in regulating sleep, maintaining BBB integrity, and preserving memory in AD.

Sleep, cognition, and BBB permeability are tightly interconnected.mAICD brain expression restores sleep and prevents vascular impairments in AD mice.mAICD interaction with GαS is necessary to preserve BBB, sleep, and cognition.mAICD redistributes astrocytes in NVUs through GαS signaling.

Sleep, cognition, and BBB permeability are tightly interconnected.

mAICD brain expression restores sleep and prevents vascular impairments in AD mice.

mAICD interaction with GαS is necessary to preserve BBB, sleep, and cognition.

mAICD redistributes astrocytes in NVUs through GαS signaling.

## Linked entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351]
- **Proteins:** ab (abrupt), APP (amyloid beta precursor protein), GAST (gastrin)
- **Diseases:** Alzheimer's disease (MONDO:0004975)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Camp (cathelicidin antimicrobial peptide) [NCBI Gene 12796] {aka CAP18, CLP, Cnlp, Cramp, FALL39, MCLP}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Aplp1 (amyloid beta precursor like protein 1) [NCBI Gene 11803], Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Gast (gastrin) [NCBI Gene 14459] {aka GAS}, Nfib (nuclear factor I/B) [NCBI Gene 18028] {aka 6720429L07Rik, CTF, E030026I10Rik, NF-I/B, NF1-B, NFI-B}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580]
- **Diseases:** Sleep disorders (MESH:D012893), cognitive decline (MESH:D003072), agitation (MESH:D011595), manic (MESH:D001714), RESEARCH (MESH:D014947), depressive symptoms (MESH:D003866), AD (MESH:D000544), memory deficits (MESH:D008569), memory decline (MESH:D060825), BBB (MESH:C536830), Astrogliosis (MESH:D005911), anxiety (MESH:D001007), sleep fragmentation (MESH:D012892), visuospatial deficits (MESH:D000377), behavioral disruption (MESH:D019958), neurofibrillary tangles (MESH:D055956), delusions (MESH:D063726), neurodegeneration (MESH:D019636), mAICD (MESH:D009436), cerebrovascular lesions (MESH:D002561), language deterioration (MESH:D007806), daily functioning (MESH:D020773), vascular impairments (MESH:D020141), emotional problems (MESH:D019973), brain inflammation (MESH:D004660), loss (MESH:D016388), neuronal atrophy (MESH:D001284), neuronal injury (MESH:D009410), neurotoxic (MESH:D020258)
- **Chemicals:** cyclic adenosine monophosphate (MESH:D000242), PVDF (MESH:C024865), sucrose (MESH:D013395), Tween (MESH:D011136), Triton X-100 (MESH:D017830), paraformaldehyde (MESH:C003043), NP-40 (MESH:C010615), ethanol (MESH:D000431), EDTA (MESH:D004492), Bis-Tris (MESH:C026272), NaCl (MESH:D012965), isoflurane (MESH:D007530), CO2 (MESH:D002245), paraffin (MESH:D010232), Dextran (MESH:D003911), HCl (MESH:D006851), methanol (MESH:D000432), DAPI (MESH:C007293), sodium deoxycholate (MESH:D003840), Tri-sodium citrate (MESH:C514290), lipid (MESH:D008055), SDS (MESH:D012967), Alexa 647 (MESH:C569686), A-31571 (-)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Ascochyta sp. AV8 (species) [taxon 372030], Homo sapiens (human, species) [taxon 9606], adeno-associated virus 2 (no rank) [taxon 10804], Adeno-associated virus (species) [taxon 272636]
- **Mutations:** L286V, M671L, K670N, M146L, I716V, V717I

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865326/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12865326/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865326/full.md

---
Source: https://tomesphere.com/paper/PMC12865326